(Q45227163)

11 December 2017

Optimal sample size determinations from an industry perspective based on the expected value of information (English)

1 reference

11 December 2017

Andrew R Willan

1

1 reference

11 December 2017

1 January 2008

1 reference

11 December 2017

1 reference

11 December 2017

5

1 reference

11 December 2017

6

1 reference

11 December 2017

587-594

1 reference

The value of information and optimal clinical trial design.

11 December 2017

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

Designing a cost-effective clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

The cost-benefit of a randomized trial to a health care organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

A dynamic programming approach to the efficient design of clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

Bayesian assessment of sample size for clinical trials of cost-effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

The sample size for a clinical trial: a Bayesian-decision theoretic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

Bayesian techniques for sample size determination in clinical trials: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

Bayesian approach to determine the number of subsequent users of a new treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

A Bayesian cost-benefit approach to the determination of sample size in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

Expected value of information and decision making in HTA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

Clinical decision making and the expected value of information

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

Determining optimal sample sizes for multi-stage randomized clinical trials using value of information methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

The assessment of the economic return from controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1740774508098413

21 January 2018

Identifiers

DOI

10.1177/1740774508098413

1 reference

11 December 2017

1 reference

PubMed ID

19029207